Patent details

EP1442133 Title: Use of Mirtazapine for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4

Basic Information

Publication number:
EP1442133
PCT Application Number:
PCT/US/2002/001248
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP027041474
PCT Publication Number:
WO/2002/064735
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
Use of Mirtazapine for improving the therapeutic response of humans having major depression and carrying the gene for apolipoprotein E4
French Title of Invention:
Utilisation de Mirtazapine pour améliorer la réponse thérapeutique des humains ayant la dépression principale et portant le gène pour l'apolipoprotein E4
German Title of Invention:
Verwendung von Mirtazapin zur Verbesserung der Behandlung von Menschen mit starken Depressionen, welche Träger des Gens für Apolipoprotein E4 sind.
SPC Number:

Dates

Filing date:
12/02/2002
Grant date:
12/12/2007
EP Publication Date:
12/12/2007
PCT Publication Date:
22/08/2002
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
04/08/2004
EP B1 Publication Date:
12/12/2007
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
12/02/2008
Expiration date:
12/02/2022
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
12/02/2002
 
 

Name:
N.V. Organon
Address:
Kloosterstraat 6, 5349 AB Oss, Netherlands (NL)

Inventor

1

Name:
MURPHY Greer, M.
Address:
United States (US)

2

Name:
SCHATZBERG Alan, F.
Address:
United States (US)

Priority

1

Priority Number:
780512
Priority Date:
12/02/2001
Priority Country:
United States (US)

2

Priority Number:
10087
Priority Date:
03/12/2001
Priority Country:
United States (US)

Classification

Main IPC Class:
C12Q 1/68;
Filing date Document type Number of pages